Springer; Barry A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Springer; Barry A..The latest application filed is for "chemically modified quinoline and quinolone derivatives useful as cb-1 inverse agonists".

Company Profile

0.8.8

Springer; Barry A. - Wilmington DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Chemically modified quinoline and quinolone derivatives useful as CB-1 inverse agonists Grant 9,815,790 - Macielag , et al. November 14, 2	2017-11-14
Chemically Modified Quinoline And Quinolone Derivatives Useful As Cb-1 Inverse Agonists App 20170057922 - Macielag; Mark J. ; et al.	2017-03-02
Methods Of Inhibiting Pro Matrix Metalloproteinase Activation App 20120302573 - JACKSON; Paul Francis ; et al.	2012-11-29
Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, asparate 101 or leucine 137 Grant 7,138,374 - Springer , et al. November 21, 2	2006-11-21
Method for the identification of ligands App 20060110732 - Bone; Roger F. ; et al.	2006-05-25
Crystal structure of the c-fms kinase domain: applications and use of heterologous substitutions of kinase insert domains for crystallization App 20060094081 - Schubert; Carsten ; et al.	2006-05-04
Method for the idenification of ligands App 20060024844 - Rentzeperis; Dionisios ; et al.	2006-02-02
Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, asparate 101 or leucine 137 App 20050159350 - Springer, Barry A. ; et al.	2005-07-21
Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, Aspartate 101 or Leucine 137 Grant 6,767,722 - Springer , et al. July 27, 2	2004-07-27
Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, aspartate 101 or leucine 137 Grant 6,737,404 - Springer , et al. May 18, 2	2004-05-18
Microplate thermal shift assay for ligand development using 5- (4"-dimethylaminophenyl) -2- (4' -phenyl) oxazole derivative fluorescent dyes App 20030175813 - Pantoliano, Michael W. ; et al.	2003-09-18
Microplate thermal shift assay for ligand development using 5-(4"dimethylaminophenyl)-2-(4'-phenyl)oxazole derivative fluorescent dyes Grant 6,569,631 - Pantoliano , et al. May 27, 2	2003-05-27
Method for identifying conditions that facilitate recombinant protein folding Grant 6,291,192 - Pantoliano , et al. September 18, 2	2001-09-18
Analogs of human basic fibroblast growth factor App 20010020004 - Springer, Barry A. ; et al.	2001-09-06
Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137 Grant 6,274,712 - Springer , et al. August 14, 2	2001-08-14
Method for determining conditions that facilitate protein crystallization Grant 6,268,158 - Pantoliano , et al. July 31, 2	2001-07-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.